Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| November 14, 2025 | $0.62 | 2025-11-13 | 2025-11-13 |
| August 15, 2025 | $0.62 | 2025-08-14 | 2025-08-14 |
| May 15, 2025 | $0.62 | 2025-05-13 | 2025-05-13 |
| February 14, 2025 | $0.62 | 2025-02-13 | 2025-02-13 |
| November 15, 2024 | $0.62 | 2024-11-14 | 2024-11-14 |
Dividends Summary
- Consistent Payer: has rewarded shareholders with 7 dividend payments over the past 1 years.
- Total Returned Value: Investors who held ABLLL shares during this period received a total of $4.32 per share in dividend income.
- Latest Payout: The most recent dividend of $0.62/share was paid 70 days ago, on November 14, 2025.
- Payment Schedule: ABLLL currently distributes dividends on a quarterly basis.
- Dividend Growth: Since 2024, the dividend payout has decreased by 0.0%, from $0.62 to $0.62.
- Dividend Reliability: ABLLL has maintained or increased its dividend for 6 consecutive payments.
Company News
Abacus Global Management announced its first annual cash dividend of $0.20 per share, payable on December 17, 2025, to shareholders of record as of December 2, 2025. The dividend represents up to 25% of adjusted net income or 55% of recurring revenue.
Abacus Global Management announced an annual cash dividend of $0.20 per share and a $10 million share repurchase program, demonstrating confidence in its long-term business model and strong financial performance.
Law firm Bragar Eagel & Squire is investigating potential claims against Abacus Global Management after a research report suggested accounting irregularities, causing the stock to drop over 21%.
Abacus Global Management will participate in two investor conferences in September 2025: B. Riley Securities Consumer & TMT Conference and Sidoti Small-Cap Virtual Conference, with key executives hosting meetings and presentations.
Pomerantz Law Firm is investigating potential securities fraud at Abacus Global Management after a Morpheus Research report alleged questionable accounting practices and revenue manipulation, causing the stock to drop 21.47%.
